Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Orathai Piboonpocanun, Mahidol University
ClinicalTrials.gov Identifier:
NCT00944515
First received: July 22, 2009
Last updated: September 8, 2014
Last verified: September 2014

July 22, 2009
September 8, 2014
August 2009
December 2015   (final data collection date for primary outcome measure)
frequence of acute sinusitis during 12 mouths of study period [ Time Frame: 12 months ] [ Designated as safety issue: Yes ]
frequence of acute sinusitis during 12 mouths of study period [ Time Frame: 12 mouths ] [ Designated as safety issue: Yes ]
Complete list of historical versions of study NCT00944515 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children
Efficacy of Azithromycin Prophylaxis in Preventing Recurrent Acute Sinusitis in Children : A Prospective, Randomized, Double-blind, Placebo Controlled Trial.

The purpose of this study is to evaluate efficacy of azithromycin prophylaxis in preventing recurrent acute sinusitis in children.

A Prospective, Randomized, Double-blind, Placebo Controlled Trial of azithromycin in preventing recurrent acute sinusitis in children

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Sinusitis
  • Drug: placebo
    placebo tablet or syrup 3 days/week
    Other Name: placebo
  • Drug: azithromycin
    azithromycin 3 days/week
    Other Name: treatment
  • Active Comparator: azithromycin
    azithrimycin 3 days/week
    Intervention: Drug: azithromycin
  • Placebo Comparator: placebo
    placebo 3 days/week
    Intervention: Drug: placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
40
December 2015
December 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • children between the age of 5 years and 15 years with the diagnosis of recurrent acute sinusitis who are attending the outpatient pediatric department, pediatric allergy clinic, and the ear, nose, throat clinic.

Exclusion Criteria:

  • patients who have allergic rhinitis, chronic sinusitis, a history of allergic reactions to azithromycin or macrolides, treatments with immunotherapy or IVIG or gentamycin solution or pneumococcal vaccine during study period.
Both
5 Years to 15 Years
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
NCT00944515
394/2551(EC4)
Yes
Orathai Piboonpocanun, Mahidol University
Mahidol University
Not Provided
Principal Investigator: Orathai - Piboonpocanun, MD Siriraj Hospital, Mahidol University
Mahidol University
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP